1. Home
  2. LGND vs GLP Comparison

LGND vs GLP Comparison

Compare LGND & GLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • GLP
  • Stock Information
  • Founded
  • LGND 1987
  • GLP 2005
  • Country
  • LGND United States
  • GLP United States
  • Employees
  • LGND N/A
  • GLP N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • GLP Oil Refining/Marketing
  • Sector
  • LGND Health Care
  • GLP Energy
  • Exchange
  • LGND Nasdaq
  • GLP Nasdaq
  • Market Cap
  • LGND 2.0B
  • GLP 1.7B
  • IPO Year
  • LGND 1992
  • GLP 2005
  • Fundamental
  • Price
  • LGND $102.19
  • GLP $52.74
  • Analyst Decision
  • LGND Strong Buy
  • GLP Hold
  • Analyst Count
  • LGND 8
  • GLP 1
  • Target Price
  • LGND $144.71
  • GLP $56.00
  • AVG Volume (30 Days)
  • LGND 118.3K
  • GLP 58.3K
  • Earning Date
  • LGND 05-08-2025
  • GLP 05-08-2025
  • Dividend Yield
  • LGND N/A
  • GLP 5.59%
  • EPS Growth
  • LGND N/A
  • GLP 16.18
  • EPS
  • LGND N/A
  • GLP 3.13
  • Revenue
  • LGND $181,488,000.00
  • GLP $17,610,371,000.00
  • Revenue This Year
  • LGND $17.68
  • GLP $38.58
  • Revenue Next Year
  • LGND $18.69
  • GLP $17.34
  • P/E Ratio
  • LGND N/A
  • GLP $16.79
  • Revenue Growth
  • LGND 53.40
  • GLP 6.04
  • 52 Week Low
  • LGND $77.43
  • GLP $37.00
  • 52 Week High
  • LGND $129.90
  • GLP $60.00
  • Technical
  • Relative Strength Index (RSI)
  • LGND 44.63
  • GLP 58.74
  • Support Level
  • LGND $98.90
  • GLP $50.93
  • Resistance Level
  • LGND $103.17
  • GLP $53.30
  • Average True Range (ATR)
  • LGND 3.05
  • GLP 2.10
  • MACD
  • LGND -0.27
  • GLP 0.48
  • Stochastic Oscillator
  • LGND 31.94
  • GLP 91.62

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About GLP Global Partners LP Common Units representing Limited Partner Interests

Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the Wholesale segment.

Share on Social Networks: